Creative Medical Technology Holdings, Inc.
CELZNASDAQHealthcare● Active
$2.17
+$0.11(+5.31%)
Market Cap$5598479
P/E Ratio—
52W High$6.25
52W Low$1.504
Creative Medical Technology Holdings, Inc. (CELZ) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CELZ · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.01M | $0.01M | $0.01M | $0.09M | $0.09M |
| Cost of Revenue | $0.13M | $0.00M | $0.00M | $0.03M | $0.05M |
| Gross Profit | ($0.12M) | $0.01M | $0.01M | $0.06M | $0.04M |
| Gross Margin %(computed) | — | 60.00% | 60.00% | 67.84% | 45.36% |
| Operating Expenses | |||||
| R&D Expenses | $2.26M | $2.40M | $1.97M | $6.27M | $0.11M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $6.02M | $5.75M | $5.63M | $10.30M | $3.17M |
| Operating Income | ($6.14M) | ($5.74M) | ($5.62M) | ($10.24M) | ($3.13M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.15M | $0.25M | $0.33M | $0.10M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $4.28M |
| Income Before Tax | ($6.00M) | ($5.49M) | ($5.29M) | ($10.14M) | $19.21M |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($6.00M) | ($5.49M) | ($5.29M) | ($10.14M) | $19.21M |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.52 | $-3.71 | $-3.76 | $-9.28 | $73.75 |
| Wtd Avg Shares | 2.38M | 1.48M | 1.41M | 1.09M | 0.26M |
| EBITDA | ($6.02M) | ($5.63M) | ($5.53M) | ($10.15M) | $23.58M |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Creative Medical Technology Holdings, Inc. data
About Creative Medical Technology Holdings, Inc. (CELZ) Income Statement
Creative Medical Technology Holdings, Inc. (CELZ) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CELZ reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -1992.02%), and net income of ($0.01B) — a net profit margin of -99916.80%.
Frequently asked questions
CELZ · 4 questionsCreative Medical Technology Holdings, Inc. (CELZ) reported revenue of $0.00B for 2025, down 45.5% year-over-year.
CELZ revenueCELZ salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08